- Home
- AFJK vs CTSO Comparison
AFJK vs CTSO Comparison
Compare AFJK & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFJK
- CTSO
- Stock Information
- Founded
- AFJK 2023
- CTSO 1997
- Country
- AFJK United States
- CTSO United States
- Employees
- AFJK N/A
- CTSO N/A
- Industry
- AFJK
- CTSO Medical/Dental Instruments
- Sector
- AFJK
- CTSO Health Care
- Exchange
- AFJK NYSE
- CTSO Nasdaq
- Market Cap
- AFJK 67.3M
- CTSO 68.2M
- IPO Year
- AFJK 2023
- CTSO N/A
- Fundamental
- Price
- AFJK $11.03
- CTSO $0.87
- Analyst Decision
- AFJK
- CTSO Strong Buy
- Analyst Count
- AFJK 0
- CTSO 3
- Target Price
- AFJK N/A
- CTSO $4.67
- AVG Volume (30 Days)
- AFJK 4.5K
- CTSO 138.6K
- Earning Date
- AFJK 01-01-0001
- CTSO 05-14-2025
- Dividend Yield
- AFJK N/A
- CTSO N/A
- EPS Growth
- AFJK N/A
- CTSO N/A
- EPS
- AFJK 0.28
- CTSO N/A
- Revenue
- AFJK N/A
- CTSO $35,594,520.00
- Revenue This Year
- AFJK N/A
- CTSO $18.72
- Revenue Next Year
- AFJK N/A
- CTSO $19.75
- P/E Ratio
- AFJK $38.90
- CTSO N/A
- Revenue Growth
- AFJK N/A
- CTSO 14.51
- 52 Week Low
- AFJK $10.24
- CTSO $0.70
- 52 Week High
- AFJK $11.20
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- AFJK N/A
- CTSO 34.05
- Support Level
- AFJK N/A
- CTSO $0.87
- Resistance Level
- AFJK N/A
- CTSO $1.16
- Average True Range (ATR)
- AFJK 0.00
- CTSO 0.06
- MACD
- AFJK 0.00
- CTSO -0.02
- Stochastic Oscillator
- AFJK 0.00
- CTSO 0.34
About AFJK AIMEI HEALTH TECHNOLOGY CO LTD
Aimei Health Technology Co Ltd is a blank check company.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.